Published in Clin Pharmacol Ther on November 01, 1990
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob Agents Chemother (2004) 1.64
Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother (1993) 1.05
In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS J (2005) 0.99
Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J (2006) 0.96
Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob Agents Chemother (1992) 0.91
Quantitative assessment of the hepatic pharmacokinetics of the antimicrobial sitafloxacin in humans using in vivoF magnetic resonance spectroscopy. Br J Clin Pharmacol (2005) 0.80
Molecular imaging in oncology. Cancer Imaging (2004) 0.75
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther (1977) 1.61
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol (1984) 1.60
Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. N Engl J Med (1990) 1.48
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics. Clin Pharmacokinet (1988) 1.42
Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. Int J Epidemiol (1995) 1.32
Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther (1984) 1.32
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol (1978) 1.23
Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res (1999) 1.19
Variable binding of propranolol in human serum. Biochem Pharmacol (1979) 1.12
Nicotine in hair of smokers and non-smokers: sampling procedure and gas chromatographic/mass spectrometric analysis. Pharmacol Toxicol (1995) 1.12
Long-term effects of inhaled nicotine. Life Sci (1996) 1.07
Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine. J Chromatogr (1984) 1.07
1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed (1994) 1.07
Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicol Appl Pharmacol (1981) 1.05
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship. Clin Pharmacol Ther (1985) 0.99
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part I--Clinical implications of penile tissue mechanical properties. Int J Impot Res (1998) 0.99
In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res (1994) 0.99
Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR. Am J Physiol (1989) 0.98
Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther (1987) 0.98
Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR Biomed (2000) 0.97
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency. Arzneimittelforschung (1985) 0.95
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma. Biochem Pharmacol (1977) 0.94
Study on the possible interaction between tenoxicam and furosemide. Arzneimittelforschung (1987) 0.93
Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration. Clin Pharmacol Ther (1986) 0.92
Hyperthermia induced polyphosphate changes in Propionibacterium acnes as studied by 31P NMR. Z Naturforsch C (1989) 0.92
Inhalation kinetics of C8 to C10 1-alkenes and iso-alkanes in the rat after repeated exposures. Pharmacol Toxicol (1993) 0.92
Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clin Pharmacol Ther (1984) 0.91
Uptake of nicotine in hair during controlled environmental air exposure to nicotine vapour: evidence for a major contribution of environmental nicotine to the overall nicotine found in hair from smokers and non-smokers. Pharmacol Toxicol (1995) 0.90
Inhibition of lipid peroxidation mediated by indolizines. Bioorg Med Chem Lett (1998) 0.88
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex. Br J Clin Pharmacol (1988) 0.87
Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients. Br J Clin Pharmacol (1989) 0.87
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics. Clin Pharmacokinet (1987) 0.87
Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast Cancer Res Treat (1995) 0.87
Accumulation of nicotine in human hair during long-term controlled exposure to a low concentration of nicotine vapour. Pharmacol Toxicol (1997) 0.87
Synthesis of 5-substituted pyrrolo[1,2-b]pyridazines with antioxidant properties. Arch Pharm (Weinheim) (2001) 0.87
Increased amine turnover in several hypothalamic noradrenaline nerve terminal systems and changes in prolactin secretion in the male rat by exposure to various concentrations of toluene. Neurotoxicology (1983) 0.86
Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics. Br J Clin Pharmacol (1997) 0.85
NMR response of non-reservoir fluids in sandstone and chalk. Magn Reson Imaging (2001) 0.85
Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol Lett (1980) 0.84
First direct demonstration of preferential release of citrate from astrocytes using [13C]NMR spectroscopy of cultured neurons and astrocytes. Neurosci Lett (1991) 0.84
Renin release regulation during acute renin inhibition in normal volunteers. Hypertension (1991) 0.84
Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients. J Cardiovasc Pharmacol (1987) 0.84
Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicol Lett (1982) 0.84
Interindividual differences in hair uptake of air nicotine and significance of cigarette counting for estimation of environmental tobacco smoke exposure. Pharmacol Toxicol (1996) 0.83
Ratio of jet cross sections at square root of s = 630 GeV and 1800 GeV. Phys Rev Lett (2001) 0.83
Changes in rat liver microsomal cytochrome P-450 and enzymatic activities after the inhalation of n-hexane, xylene, methyl ethyl ketone and methylchloroform for four weeks. Scand J Work Environ Health (1981) 0.83
Effect of lifelong nicotine inhalation on bone mass and mechanical properties in female rat femurs. Calcif Tissue Int (1999) 0.83
Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump. Eur J Clin Pharmacol (1985) 0.83
Sodium-calcium balance and cardiac function with isotonic iodixanol. An experimental study in the isolated rat heart. Invest Radiol (1993) 0.83
Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung. Toxicology (1982) 0.82
Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients. Xenobiotica (2008) 0.82
Effect of nicotine on the enterochromaffin like cells of the oxyntic mucosa of the rat. Life Sci (1993) 0.82
Automated heparin-delivery system to control activated partial thromboplastin time: evaluation in normal volunteers. Circulation (1999) 0.82
The binding of quinidine to protein fractions of normal human sera. Biochem Pharmacol (1975) 0.81
Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans. J Cardiovasc Pharmacol (1991) 0.81
Inclusive jet production in pp(macro) collisions. Phys Rev Lett (2001) 0.81
Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide. Mutat Res (1999) 0.80
Differences in the serum protein binding of prazosin in man and rat. Biochem Pharmacol (1984) 0.80
The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins. Br J Clin Pharmacol (1989) 0.80
Measurement of dijet azimuthal decorrelations at central rapidities in pp collisions at sqrt s =1.96 TeV. Phys Rev Lett (2005) 0.80
Contractile responses to electrolyte changes during coronary bolus perfusion. A comparative study in isolated rat, guinea pig, and rabbit hearts. Invest Radiol (1995) 0.79
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. Eur J Clin Pharmacol (1983) 0.79
Metabolic interaction of n-hexane and methyl ethyl ketone in vitro in a head space rat liver S9 vial equilibration system. Pharmacol Toxicol (1998) 0.79
Pharmacokinetics of quinidine related to plasma protein binding in man. Eur J Clin Pharmacol (1979) 0.79
Dose dependent induction of rat liver microsomal cytochrome P-450 and microsomal enzymatic activities after inhalation of toluene and dichloromethane. Acta Pharmacol Toxicol (Copenh) (1982) 0.79
A comparison of the binding and distribution of benzo[a]pyrene in human and rat serum. Toxicology (1987) 0.79
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma. Cancer Chemother Pharmacol (1987) 0.79
Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients. Transplantation (1985) 0.79
Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels. Transfus Clin Biol (1998) 0.79
Polychlorinated terphenyls: alterations in liver morphology and induction of cytochrome P-450. Toxicology (1986) 0.78
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans. J Cardiovasc Pharmacol (1991) 0.78
Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther (1992) 0.78
Drug interactions with calcium antagonists. Pharmacol Ther (1990) 0.78
Effects of acrylonitrile on rat liver cytochrome P-450, benzo(a)pyrene metabolism and serum hormone levels. Toxicol Lett (1980) 0.78
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Cancer Chemother Pharmacol (1990) 0.78
Phthalate esters I: Effects on cytochrome P-450 mediated metabolism in rat liver and lung, serum enzymatic activities and serum protein levels. Arch Toxicol (1982) 0.78
Search for R-parity violating supersymmetry in two-muon and four-jet topologies. Phys Rev Lett (2002) 0.78
Increased microsomal metabolism of n-hexane in rat kidney and liver after inhalation of isopropanol. Arch Toxicol Suppl (1984) 0.78
Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure. Br J Clin Pharmacol (1989) 0.78
Correlation between changes in enzymatic activities and induction of different forms of rat liver microsomal cytochrome P-450 after phenobarbital-, 3-methylcholanthrene- and 16 alpha-cyanopregnenolone treatment. Acta Pharmacol Toxicol (Copenh) (1980) 0.77
Short-term exposure of rodents to diesel exhausts: usefulness for studies of genotoxic and immunotoxic effects. Chem Biol Interact (1999) 0.77
Improved convection compensating pulsed field gradient spin-echo and stimulated-echo methods. J Magn Reson (2000) 0.77
Dexamethasone and dexamethasone phosphate detected by 1H and 19F NMR spectroscopy in the aqueous humour. Exp Eye Res (1998) 0.77
Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function. Eur J Clin Pharmacol (1998) 0.77
Characterization of plasma lipids in patients with malignant disease by 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography. Blood (1995) 0.77
Search for large extra dimensions in dielectron and diphoton production. Phys Rev Lett (2001) 0.77
The binding of thio-TEPA in human serum and to isolated serum protein fractions. Cancer Chemother Pharmacol (1987) 0.77
Increased binding of quinidine to serum albumin and lipoproteins in anuric rats. Eur J Pharmacol (1975) 0.77
Pharmacokinetics of thio-TEPA at two different doses. Cancer Chemother Pharmacol (1988) 0.77
Effects of polychlorinated terphenyls and paraffins on rat liver microsomal cytochrome P-450 and in vitro metabolic activities. Arch Toxicol (1981) 0.77
Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res (2000) 0.77
Detection of dexamethasone in the cornea and lens by NMR spectroscopy. Graefes Arch Clin Exp Ophthalmol (1999) 0.77
Proton n.m.r. of ferredoxin from Clostridium pasteurianum. Int J Biol Macromol (1989) 0.76
Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation. Ther Drug Monit (1985) 0.76
An anion binding site in the active centre of phospholipase C from Bacillus cereus. Biochem Int (1984) 0.76
Pharmacokinetics of midazolam and alfentanil in outpatient general anesthesia. A study with concomitant thiopentone, flumazenil or placebo administration. Acta Anaesthesiol Scand (1988) 0.76
Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension. J Hypertens (1989) 0.76
The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril. Br J Clin Pharmacol (1989) 0.76